Abstract

The role of liver biopsy in the management of patients with chronic liver disease has much evolved in the recent years. Its importance in diagnosis, staging and prognosis largely depends on the indication and on the context. In chronic viral hepatitis, the role of liver biopsy has been reduced because of the major developments and improvements in the virological diagnosis of viral infection and because of the recent validation of non-invasive tests for fibrosis evaluation which offer alternative strategies for therapeutic decision and follow-up. Liver biopsy remains however useful for the identification of associated diseases and for the detection of some complications. In many other indications, liver biopsy remains the gold standard for the diagnosis and the staging of the disease. Moreover, guided liver biopsy remains essential for the diagnosis of focal liver lesions.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.